San Francisco, January, 2015
Successful Acquisition of BioPharmaceutical Intellectual Property
Steven R. Gerbsman, Principal of Gerbsman Partners, announced today the success in acquiring various Patents/Intellectual Property for a BioPharmaceutical company. The Patents/Intellectual Property were acquired from a company in bankruptcy.
Gerbsman Partners provided Insolvency negotiation skills and Investment Banking leadership and facilitated the sale of the Patents/Intellectual Property. Due to market conditions and the insolvency of company holding the Patents/Intellectual Property, the acquiring BioPharmaceutical company made of the decision to retain Gerbsman Partners to represent them in the acquisition of the Patents/Intellectual Property.
Gerbsman Partners provided leadership to the company with:
1. Consulting, Negotiation and Investment Banking Life Science domain expertise in developing the strategic action plans for the negotiation of the Patents/Intellectual Property;
2. The ability to “Manage the Process” among Lawyers, Advisors, the BioPharmaceutical company and the Receiver;
3. Daily/weekly Communications with the acquiring BioPharmaceutical company senior management and legal counsel.
About Gerbsman Partners
Gerbsman Partners focuses on maximizing enterprise value for stakeholders and shareholders in under-performing, under-capitalized and under-valued companies and their Intellectual Property. Since 2001, Gerbsman Partners has been involved in maximizing value for 88 Technology, Life Science, Medical Device, Solar, Fuel Cell and Digital Marketing/Social Commerce companies and their Intellectual Property and has restructured/terminated over $810 million of real estate executory contracts and equipment lease/sub-debt obligations. Since inception in 1980, Gerbsman Partners has been involved in over $2.3 billion of financings, restructurings and M&A transactions.
Gerbsman Partners has offices and strategic alliances in San Francisco, Boston, New York, Washington, DC, McLean, VA, Europe and Israel.